Beckman Coulter expands collaboration with Fujirebio for neurodegenerative disease assays
New assays are being developed for the recently launched Beckman Coulter DxI 9000 Immunoassay Analyzer American firm Beckman Coulter Diagnostics, a clinical diagnostics leader, and Japan-based Fujirebio, a leader in neurological markers and In Vitro …